Cargando…
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients
The PAX5 gene is altered in 30% of BCP-ALL patients and PAX5 chromosomal translocations account for 2–3% of cases. Although PAX5 fusion genes significantly affect the transcription of PAX5 target genes, their role in sustaining leukemia cell survival is poorly understood. In an in vitro model of PAX...
Autores principales: | Cazzaniga, Valeria, Bugarin, Cristina, Bardini, Michela, Giordan, Marco, te Kronnie, Geertruy, Basso, Giuseppe, Biondi, Andrea, Fazio, Grazia, Cazzaniga, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359315/ https://www.ncbi.nlm.nih.gov/pubmed/25595912 |
Ejemplares similares
-
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia
por: Hasegawa, D, et al.
Publicado: (2013) -
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia
por: Vendramini, Elena, et al.
Publicado: (2017) -
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL
por: Accordi, Benedetta, et al.
Publicado: (2010) -
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
por: Fazio, Grazia, et al.
Publicado: (2022) -
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis
por: Trentin, Luca, et al.
Publicado: (2016)